Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevenar13 vs Pneumovax in Kidney and Liver Transplant Patients
NCT01781871Phase 4Completed
- Sponsor
- Helsinki University Hospital
- Start
- Jan 2013
- Primary completion
- Oct 2017
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of pneumococcal 13-valent conjugate vaccine in pneumococcal infection, sponsored by Helsinki University Hospital. Started Jan 2013; status: completed.
02
Drugs
pneumococcal 13-valent conjugate vaccine
03
Conditions
pneumococcal infection
Beyond the preview
Go deeper on NCT01781871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01781871.